Brief: Oncolytics Biotech® reports Q2 results
11/08/2022 12:14
Aug 11 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND RECENT OPERATIONAL HIGHLIGHTS
* Q2 LOSS PER SHARE C$0.09
* $33.7 MILLION IN CASH AND CASH EQUIVALENTS PROVIDES
PROJECTED
RUNWAY INTO SECOND HALF OF 2023
Source text for Eikon: ID:nCNWVT7Jla
Further company coverage: ONC.TO
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer